fda glp-1 compounding enforcement news october 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA GLP-1 Compounding Crackdown

However, because weight loss can change your thyroid hormone requirements, it is essential to monitor your levels closely with your GP, as your dose of levothyroxine may need to be adjusted over time

Because the effectiveness of lamotrigine depends on maintaining a steady concentration in the bloodstream, anything that changes how the drug is absorbed or processed by the body deserves a closer look

While final details may continue to evolve, individuals may qualify if they meet the following general requirements: Enrollment in Medicare Part D or a Medicare Advantage plan that includes prescription drug coverage A determination by their physician that a GLP-1 medication is appropriate Meeting defined health criteria, such as obesity or certain related conditions Approval of a prior authorization request submitted by their doctor It is important to understand that not all beneficiaries will qualify for the program

Enhanced MSC chondrogenesis following delivery of TGF-3 from alginate microspheres within hyaluronic acid hydrogels in vitro and in vivo

Send us your tattoo pictures on WhatsApp (lower right corner icon) to give you a personalized offer